Farmer Bros (FARM) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
24 Dec, 2025Executive summary
Net sales for Q2 FY2025 increased to $90 million, driven by higher pricing despite a decline in unit sales, and supported by brand and SKU rationalization, inventory management, and sales team realignment.
Gross margin improved to 43.1%, up 270 basis points year-over-year, reflecting pricing actions and operational efficiencies.
Adjusted EBITDA rose to $5.9 million, nearly $3.6 million higher than the prior year, with margin expanding to 6.6%.
Net income for Q2 FY2025 was $0.2 million, down from $2.7 million in the prior year, impacted by a $1.5 million loss on asset disposals.
Leadership changes and operational initiatives, including SKU rationalization and DSD route optimization, continued to progress.
Financial highlights
Net sales were $90.0 million for Q2 FY2025, up 0.6% year-over-year; gross profit increased to $38.8 million (43.1% margin).
Adjusted EBITDA was $5.9 million for Q2, up from $2.3 million year-over-year; margin improved to 6.6%.
Net income was $0.2 million for Q2, with a six-month net loss of $4.8 million.
Operating expenses rose to $37.8 million (42% of sales), mainly due to fewer asset disposal gains.
Cash and cash equivalents stood at $5.5 million, with $23.3 million in outstanding borrowings and $23.7 million available under the credit facility as of December 31, 2024.
Outlook and guidance
Management remains focused on top-line growth, customer expansion, and product penetration, while optimizing operations.
Company expects to complete SKU rationalization and specialty brand rollout by end of Q3 FY2025.
Capital expenditures for fiscal 2025 are expected to be $9–11 million, funded by operations and credit facility.
Liquidity and credit facility are considered sufficient for the next 12 months and beyond.
Latest events from Farmer Bros
- Shareholders to vote on $1.29/share cash merger; board unanimously recommends approval.FARM
Proxy filing27 Mar 2026 - Shareholders are asked to approve a $1.29 per share cash merger, unanimously backed by the board.FARM
Proxy Filing17 Mar 2026 - Shareholders to vote on $1.29 per share cash merger; board and key holders support approval.FARM
Proxy Filing4 Mar 2026 - Net loss reached $4.9M as sales and margins declined amid persistent cost pressures.FARM
Q2 202613 Feb 2026 - Gross margin rose to 39.3% and net loss narrowed as DSD focus drove operational gains.FARM
Q4 202420 Jan 2026 - Net sales and gross margin rose, but net loss widened to $5 million on higher expenses.FARM
Q1 202515 Jan 2026 - Net sales fell 4.1% and gross margin dropped to 39.7%, but net loss improved to $4 million.FARM
Q1 202623 Dec 2025 - Shelf registration allows up to $175M in securities for broad corporate use, with robust governance.FARM
Registration Filing16 Dec 2025 - Shelf registration allows up to $175M in securities for flexible capital needs and strategic growth.FARM
Registration Filing16 Dec 2025